{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2
  ],
  "modelUsed": "gemini-2.5-pro",
  "metadata": {
    "studyName": "A Phase 2, Open-label Study to Assess Copper and Molybdenum Balance in Participants with Wilson Dise",
    "titles": [
      {
        "id": "title_1",
        "text": "A Phase 2, Open-label Study to Assess Copper and Molybdenum Balance in Participants with Wilson Disease Treated with ALXN1840",
        "type": {
          "code": "Official Study Title",
          "codeSystem": "USDM",
          "decode": "Official Study Title"
        },
        "instanceType": "StudyTitle"
      },
      {
        "id": "title_2",
        "text": "Copper and Molybdenum Balance in Participants with Wilson Disease Treated with ALXN1840",
        "type": {
          "code": "Brief Study Title",
          "codeSystem": "USDM",
          "decode": "Brief Study Title"
        },
        "instanceType": "StudyTitle"
      }
    ],
    "identifiers": [
      {
        "id": "sid_1",
        "text": "ALXN1840-WD-204",
        "scopeId": "org_1",
        "instanceType": "StudyIdentifier",
        "identifierType": {
          "code": "SponsorProtocolNumber",
          "codeSystem": "USDM",
          "decode": "Sponsor Protocol Number"
        }
      },
      {
        "id": "sid_2",
        "text": "2020-001104-41",
        "scopeId": "org_4",
        "instanceType": "StudyIdentifier",
        "identifierType": {
          "code": "EudraCT",
          "codeSystem": "USDM",
          "decode": "EudraCT Number"
        }
      },
      {
        "id": "sid_3",
        "text": "119006",
        "scopeId": "org_2",
        "instanceType": "StudyIdentifier",
        "identifierType": {
          "code": "IND",
          "codeSystem": "USDM",
          "decode": "FDA IND Number"
        }
      },
      {
        "id": "sid_4",
        "text": "NCT04573309",
        "scopeId": "org_3",
        "instanceType": "StudyIdentifier",
        "identifierType": {
          "code": "NCT",
          "codeSystem": "USDM",
          "decode": "ClinicalTrials.gov Identifier"
        }
      }
    ],
    "organizations": [
      {
        "id": "org_1",
        "name": "Alexion Pharmaceuticals, Inc.",
        "type": {
          "id": "7049cc2c-145b-4693-b2cd-884b90f92f90",
          "code": "C54086",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Pharmaceutical Company",
          "instanceType": "Code"
        },
        "identifier": "Alexion Pharmaceuticals, Inc.",
        "identifierScheme": "DUNS",
        "instanceType": "Organization"
      },
      {
        "id": "org_2",
        "name": "US Food and Drug Administration (FDA)",
        "type": {
          "id": "36376b13-bc7b-4a20-8507-044de68ba622",
          "code": "C25461",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Regulatory Agency",
          "instanceType": "Code"
        },
        "identifier": "US Food and Drug Administration (FDA)",
        "identifierScheme": "DUNS",
        "instanceType": "Organization"
      },
      {
        "id": "org_3",
        "name": "ClinicalTrials.gov",
        "type": {
          "id": "36dd6e2d-7cc8-4469-b857-0a467d814193",
          "code": "C19326",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Healthcare Facility",
          "instanceType": "Code"
        },
        "identifier": "ClinicalTrials.gov",
        "identifierScheme": "DUNS",
        "instanceType": "Organization"
      },
      {
        "id": "org_4",
        "name": "EudraCT",
        "type": {
          "id": "f549a8ee-c4c5-4af1-85fc-e969f0b39aa8",
          "code": "C19326",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Healthcare Facility",
          "instanceType": "Code"
        },
        "identifier": "EudraCT",
        "identifierScheme": "DUNS",
        "instanceType": "Organization"
      }
    ],
    "roles": [
      {
        "id": "role_1",
        "name": "Sponsor",
        "code": {
          "code": "Sponsor",
          "codeSystem": "USDM",
          "decode": "Sponsor"
        },
        "organizationIds": [
          "org_1"
        ],
        "instanceType": "StudyRole"
      },
      {
        "id": "role_2",
        "name": "Regulatory Authority",
        "code": {
          "code": "Regulatory Agency",
          "codeSystem": "USDM",
          "decode": "Regulatory Agency"
        },
        "organizationIds": [
          "org_2"
        ],
        "instanceType": "StudyRole"
      },
      {
        "id": "role_3",
        "name": "Registry",
        "code": {
          "code": "Sponsor",
          "codeSystem": "USDM",
          "decode": "Sponsor"
        },
        "organizationIds": [
          "org_3"
        ],
        "instanceType": "StudyRole"
      },
      {
        "id": "role_4",
        "name": "Registry",
        "code": {
          "code": "Sponsor",
          "codeSystem": "USDM",
          "decode": "Sponsor"
        },
        "organizationIds": [
          "org_4"
        ],
        "instanceType": "StudyRole"
      }
    ],
    "indications": [
      {
        "id": "ind_1",
        "name": "Wilson Disease",
        "isRareDisease": false,
        "instanceType": "Indication",
        "description": "Participants with Wilson Disease Treated with ALXN1840"
      }
    ],
    "studyPhase": {
      "code": "Phase2",
      "codeSystem": "USDM",
      "decode": "Phase2"
    },
    "studyType": "Interventional"
  },
  "rawResponse": {
    "titles": [
      {
        "id": "title_1",
        "text": "A Phase 2, Open-label Study to Assess Copper and Molybdenum Balance in Participants with Wilson Disease Treated with ALXN1840",
        "type": {
          "code": "OfficialStudyTitle",
          "codeSystem": "http://www.cdisc.org/USDM/titleType",
          "decode": "Official Study Title"
        },
        "instanceType": "StudyTitle"
      },
      {
        "id": "title_2",
        "text": "Copper and Molybdenum Balance in Participants with Wilson Disease Treated with ALXN1840",
        "type": {
          "code": "BriefStudyTitle",
          "codeSystem": "http://www.cdisc.org/USDM/titleType",
          "decode": "Brief Study Title"
        },
        "instanceType": "StudyTitle"
      }
    ],
    "identifiers": [
      {
        "id": "sid_1",
        "text": "ALXN1840-WD-204",
        "identifierType": "SponsorProtocolNumber",
        "issuingOrganization": "Alexion Pharmaceuticals, Inc.",
        "instanceType": "StudyIdentifier"
      },
      {
        "id": "sid_2",
        "text": "2020-001104-41",
        "identifierType": "EudraCT",
        "issuingOrganization": "EudraCT",
        "instanceType": "StudyIdentifier"
      },
      {
        "id": "sid_3",
        "text": "119006",
        "identifierType": "IND",
        "issuingOrganization": "FDA",
        "instanceType": "StudyIdentifier"
      },
      {
        "id": "sid_4",
        "text": "NCT04573309",
        "identifierType": "NCT",
        "issuingOrganization": "ClinicalTrials.gov",
        "instanceType": "StudyIdentifier"
      }
    ],
    "organizations": [
      {
        "id": "org_1",
        "name": "Alexion Pharmaceuticals, Inc.",
        "type": {
          "code": "Sponsor",
          "codeSystem": "http://www.cdisc.org/USDM/organizationType",
          "decode": "Sponsor"
        },
        "role": "Sponsor",
        "instanceType": "Organization"
      },
      {
        "id": "org_2",
        "name": "US Food and Drug Administration (FDA)",
        "type": {
          "code": "RegulatoryAuthority",
          "codeSystem": "http://www.cdisc.org/USDM/organizationType",
          "decode": "Regulatory Authority"
        },
        "role": "Regulatory Authority",
        "instanceType": "Organization"
      },
      {
        "id": "org_3",
        "name": "ClinicalTrials.gov",
        "type": {
          "code": "Registry",
          "codeSystem": "http://www.cdisc.org/USDM/organizationType",
          "decode": "Clinical Study Registry"
        },
        "role": "Registry",
        "instanceType": "Organization"
      },
      {
        "id": "org_4",
        "name": "EudraCT",
        "type": {
          "code": "Registry",
          "codeSystem": "http://www.cdisc.org/USDM/organizationType",
          "decode": "Clinical Study Registry"
        },
        "role": "Registry",
        "instanceType": "Organization"
      }
    ],
    "studyPhase": {
      "code": "Phase2",
      "codeSystem": "http://www.cdisc.org/USDM/studyPhase",
      "decode": "Phase 2"
    },
    "studyType": "Interventional",
    "indication": {
      "id": "ind_1",
      "name": "Wilson Disease",
      "description": "Participants with Wilson Disease Treated with ALXN1840",
      "instanceType": "Indication"
    }
  }
}